miRNA‐4317 suppresses human gastric cancer cell proliferation by targeting ZNF322
Authors:
Open Access
- 7 September 2017
- journal article
- research article
- Published by Wiley in Cell Biology International
- Vol. 42 (8) , 923-930
Abstract
Studies have shown that miR‐4317 is dysregulated in tumor, but the biologic role of miR‐4317 in tumor development and progression remains unknown. The present study aimed to investigate the role of miR‐4317 in human gastric cancer. Quantitative real‐time PCR was used to quantify miR‐4317 expression levels in clinical gastric cancer specimens and cell lines. MTT, colony formation and cell cycle assays were performed to identify the contributions of miR‐4317 to cell proliferation in gastric cancer cell lines. The results showed that miR‐4317 was significantly decreased in 17 clinical gastric cancer specimens compared with adjacent non‐tumor stomach tissues. Forced expression of miR‐4317 suppressed gastric cancer cell proliferation and blocked S‐G2/M transition. Bioinformatics and dual‐luciferase reporter assays confirmed that ZNF322 is a direct target of miR‐4317. Silencing ZNF322 recapitulated the cellular and molecular effects seen upon miR‐4317 overexpression. These findings indicate that miR‐4317 represses the proliferation of gastric cancer cell, at least in part, by targeting and suppressing ZNF322 and that it may serve as a therapeutic target for gastric cancer treatment.Keywords
Funding Information
- Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University (2016LHM-KFKT003)
This publication has 12 references indexed in Scilit:
- Zinc finger proteins in cancer progressionJournal of Biomedical Science, 2016
- Differences in gastric cancer survival between the U.S. and ChinaJournal of Surgical Oncology, 2015
- Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)Journal of Cancer Research and Clinical Oncology, 2013
- Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic neviCell and tissue research, 2012
- Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibilityCarcinogenesis, 2012
- microRNAs: Master Regulators as Potential Therapeutics in CancerAnnual Review of Pharmacology and Toxicology, 2011
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- Combination therapy with docetaxel and S-1 as a first-line treatment in patients with advanced or recurrent gastric cancer: a retrospective analysisWorld Journal of Surgical Oncology, 2010
- ZNF322, a novel human C2H2 Krüppel-like zinc-finger protein, regulates transcriptional activation in MAPK signaling pathwaysBiochemical and Biophysical Research Communications, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001